DNM1L and neoplasm: Specifically, in CRC cells bearing the BRAFV600E mutation, the activation of the MEK/ERK signaling axis facilitates Drp1 phosphorylation at Ser616, culminating in mitochondrial fragmentation and subsequent tumor progression (27).